The ribonucleoside diphosphate reductase inhibitor (E)-2'-deoxy- (fluoromethylene)cytidine as a cytotoxic radiosensitizer in vitro

Cancer Research

Volumn 59, Issue 20, 1999, Pages 5219-5226

  Coucke, Philippe A ^a   Decosterd, Laurent A ^a   Li, Ye Xiong ^a   Cottin, Eliane ^a   Chen, Xiaoguang ^a   Sun, Lin Quan ^a   Stern, Sabine ^a   Paschoud, Nicolas ^a   Denekamp, Juliana ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEOTIDE; TEZACITABINE;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CLONOGENIC ASSAY; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DIVISION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYADENINE NUCLEOTIDES; DEOXYCYTIDINE; DEOXYGUANINE NUCLEOTIDES; HUMANS; RADIATION-SENSITIZING AGENTS; RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE; TUMOR CELLS, CULTURED;

EID: 0032697561     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Shewach, D. S., Ellero, J., Mancini, W. R., and Ensminger, W. D. Decrease in TTP mediated by 5′-bromo-2′-deoxyuridine exposure in a human glioblastoma cell line. Biochem. Pharmacol., 43: 1579-1585, 1992.
2. Baker, C. H., Banzon, J., Bollinger, J. M., and Stubbe, J. 2′Deoxy-2′methylencytidine and 2′-deoxy-2′,2′-difluorocytidine 5′-diphosphate: potent mechanism-based inhibitors of ribonucleotide reductase. J. Med. Chem., 34: 1879-1885, 1991.
3. Grindey, G. B., Hertel, L. W., and Plunkett, W. Cytotoxicity and antitumor activity of 2′,2′-difluorodeoxycytidine (gemcitabine). Cancer Investig., 8: 313, 1990.
4. Hertel, L. W., Boder, G., Kroin, J. S., Rinzel, S. M., Poore, G. A., Todd, G. C., and Grindey, G. B. Evaluation of the antitumor activity of gemcitabine (2′,2′-difluoro-2′-deoxycytidine). Cancer Res., 50: 4417-4422, 1990.
5. Huang, P., Chubb, S., Hertel, L. W., Grindey, G. B., and Plunkett, W. Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Res., 51: 6110-6117, 1991.
6. Kinsella, T. J., Kunugi, K. A., and Yen, Y. Hydroxyurea-mediated radiosensitization: an in vitro study in a human squamous cell cancer cell line (KB). In: Abstract II-49 Ninth International Conference on Chemical Modifiers of Cancer Treatment, pp. 181-182. Oxford, United Kingdom: Christ Church, 1995.
7. Kuo, M. L., and Kinsella, T. J. Radiosensitization by hydroxyurea in a cervical carcinoma cell line, Caski. In: Abstract 11-50 Ninth International Conference on Chemical Modifiers of Cancer Treatment, pp. 183-184 Oxford, United Kingdom: Christ Church, 1995.
8. Lawrence, T. S., Chang, E., Y., Hahn, T. M., Hertel, L. W., and Shewach, D. S. Radiosensitization of pancreatic cells by 2′,2′-difluoro-2′-deoxycytidine. Int. J. Radiat. Oncol. Biol. Phys., 34: 867-872, 1996.
9. Rockwell, S., and Grindey, G. B. Effect of 2′,2-difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitro. Oncol. Res., 4: 5151-5155, 1992.
10. Shewach, D. S., Hahn, T. M., Chang, E., Hertel, L. W., and Lawrence, T. S. Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Res., 54: 3218-3223, 1994.
11. Snyder, R. D. Effect of 2′-deoxy-2′(fluoromethylene) cytidine on the ultraviolet and x-ray sensitivity of HeLa cells. Oncol. Res., 6: 177-182, 1994.
12. Stehman, F. B., Bundy, B. N., Thomas, G., Keys, H. M., Fowler, W. C., Mortel, R., and Creasman, W. T. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group Trial. J. Clin. Oncol., 11: 1523-1528, 1993.
13. Sun, L-Q., Li, Y-X., Guillou, L., Mirimanoff, R-O., and Coucke, P. A. Antitumor and radiosensitizing effects of (E)-2′-deoxy-2′(fluoromethylene)cytidine, a novel inhibitor of ribonucleoside diphosphate reductase on human colon carcinoma xenografts in nude mice. Cancer Res., 57: 4023-4028, 1997.
14. Sun, L-Q., Li, Y-X., Guillou, L., and Coucke, P. A. (E)-2′-Deoxy-2′(fluoromethylene)cytidine potentiates radioresponse of two human solid tumor xenografts. Cancer Res., 58: 5411-5417, 1998.
15. Vokes, E. E., Stupp, R., Haraf, D. J., Moran, W., Malone, D., Wenig, B., Sweeney, P., and Weichselbaum, R. R. Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancers. Semin. Oncol., 22 (Suppl. 6): 47-52, 1995.
16. Di Pierro, D., Tavazzi, B., Perno, C. F., Bartolini, E., Calio, R., Giardina, B., and Lazzarino, G. An ion-pairing high-performance liquid chromatography method for the direct simultaneous determination of nucleotides, desoxynucleotides, nicotinic coenzymes, oxypurines, nucleosides and bases in perchloric acid cell extracts. Anal. Biochem., 231: 407-412, 1995.
17. Heinemann, V., Xu, Y-Z., Chubb, S., Sen, A., Hertel, L. W., Grindey, G. B., and Plunkett, W. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′-difluorodeoxycytidine. Mol. Pharmacol., 38: 567-572, 1990.
18. Matthews, D. P., Persichetti, R. A., Sabol, J. S., Stewart, K. T., and McCarthy, J. R. Improved synthesis of (E)-2′-deoxy-2′-(fluoromethylene)cytidine - a potent inhibitor of ribonucleotide diphosphate reductase. Nucleosides Nucleotides, 12: 115-123, 1993.
19. McCarthy, J. R, Matthews, D. P., Stemerick, D. M., Huber, E. W., Bey, P., Lippert, B. J., Snyder, R. D., and Sunkara, P. S. Stereospecific method to E and Z terminal fluoro olefins and application to the synthesis of 2′-deoxy-2′-fluoromethylene nucleosides as potential inhibitors of ribonucleoside diphosphate reductase. J. Am. Chem. Soc., 113: 7439-7440, 1991.
20. Bitonti, A. I., Dumont, J. A., Bush, T. L., Cashman, E. A., Cross-Doersen, D. E., Wright, P. S., Matthews, D. P., McCarthy, J. R., and Kaplan, D. A. Regression of human breast tumor xenografts in response to (E)-2′-deoxy-2′-(fluoromethylene)cytidine, an inhibitor of ribonucleotide diphosphate reductase. Cancer Res., 54: 1485-1490, 1994.
21. Bitonti, A. J., Bush, T. L, Lewis, M. T., and Sunkara, P. S. Response of human colon and prostate tumor xenografts to (E)-2′-deoxy-2′-(fluoromethylene)cytidine, an inhibitor of ribonucleotide reductase. Anticancer Res., 15: 1179-1182, 1995.
22. Piepmeyer, J., Rabidou, N., Schold, C., Bitonti, A. J., Prakash, N. J., and Bush, T. L. In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101.731, a novel ribonucleotide diphosphate reductase inhibitor. Cancer Res., 56: 539-361, 1996.
23. 3 cells. Cancer Chemother. Pharmacol., 41: 268-274, 1998.
24. Decosterd, L. A., Cottin, E., Chen, X., Lejeune, F., Mirimanoff, R. O., Biollaz, J., and Coucke, P. A. Simultaneous determination of deoxyribonucleosides in the presence of ribonucleoside triphosphates in human carcinoma cells by high performance liquid chromatography. Anal. Biochem., 270: 59-68, 1999.
25. Huang, P., and Plunkett, W. Induction of apoptosis by gemcitabine. Semin. Oncol., 22: 19-25, 1995.
26. Radford, I. R., and Murphy, T. K. Radiation response of mouse lymphoid and myeloid cell lines: different signals can lead to apoptosis and may influence sensitivity to killing by DNA double strand breakage. Int. J. Radiat. Biol., 65: 229-239, 1994.